SCA
DPLO

Summit Creek Advisors’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Summit Creek Advisors’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-359,435
Closed -$4.53M – 55
2016
Q4 		$4.53M Buy
359,435
+62,830
+21% +$1.17M 0.77% 46
2016
Q3 		$8.31M Buy
296,605
+80,220
+37% +$2.69M 1.36% 39
2016
Q2 		$7.57M Sell
216,385
-15,405
-7% -$484K 1.29% 39
2016
Q1 		$6.35M Buy
+231,790
New +$6.83M 1% 42

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
HIM
Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Summit Creek Advisors's DPLO Position: Q1 2017 in Review

Summit Creek Advisors sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2017, closing a stake of 359,435 shares — an estimated $4.53M sold.

Summit Creek Advisors first reported a position in DPLO in Q1 2016 and held it in 4 quarters. The position peaked at $8.31M in Q3 2016. 155 funds tracked by Wall St. Rank hold DPLO as of Q1 2017.

  • Summit Creek Advisors reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2017 after selling out during the quarter.
  • Summit Creek Advisors sold 359,435 DIPLOMAT PHARMACY, INC. shares in Q1 2017, an estimated $4.53M.
  • Summit Creek Advisors first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2016 and held it in 4 quarters.
  • Summit Creek Advisors's DIPLOMAT PHARMACY, INC. position peaked at $8.31M in Q3 2016.
  • 155 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2017.

Based on Summit Creek Advisors's 13F filing for Q1 2017, filed 21 Apr 2017.